SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-025652
Filing Date
2017-05-09
Accepted
2017-05-09 16:36:33
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v464649_10q.htm 10-Q 364847
2 EXHIBIT 31.1 v464649_ex31-1.htm EX-31.1 11441
3 EXHIBIT 31.2 v464649_ex31-2.htm EX-31.2 11453
4 EXHIBIT 32.1 v464649_ex32-1.htm EX-32.1 4382
5 EXHIBIT 32.2 v464649_ex32-2.htm EX-32.2 4274
  Complete submission text file 0001144204-17-025652.txt   3750816

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20170331.xml EX-101.INS 926318
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20170331.xsd EX-101.SCH 39095
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20170331_cal.xml EX-101.CAL 33937
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20170331_def.xml EX-101.DEF 203859
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20170331_lab.xml EX-101.LAB 268997
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20170331_pre.xml EX-101.PRE 241702
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 17827024
SIC: 2834 Pharmaceutical Preparations